𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation

✍ Scribed by Nikolai V Naoumov; A.Ross Lopes; Patrizia Burra; Lucio Caccamo; Rosa M Iemmolo; Robert A de Man; Margaret Bassendine; John G O'Grady; Bernard C Portmann; Gaya Anschuetz; Catherine A Barrett; Roger Williams; Mark Atkins


Book ID
119526567
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
130 KB
Volume
34
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prevention of hepatitis B recurrence aft
✍ Shusen Zheng; Yaomin Chen; Tingbo Liang; Anwei Lu; Weilin Wang; Yan Shen; Min Zh πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 1 views

The aim of our study was to determine the outcomes of liver transplant recipients receiving either lamivudine (LAM) monotherapy or LAM combined with low-dose intramuscular (IM) hepatitis B Immunoglobulin (HBIG) therapy. We performed a retrospective review of the medical records of patients that had